| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RLAY | Common Stock | Sale | -$1.53K | -245 | -0.06% | $6.26 | 432K | Jun 27, 2024 | Direct | F1, F2 |
| transaction | RLAY | Common Stock | Award | $11.7K | +2.11K | +0.49% | $5.54 | 434K | Jun 30, 2024 | Direct | F2, F3, F4 |
| Id | Content |
|---|---|
| F1 | Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on June 26, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. |
| F2 | Includes 383,442 shares underlying RSUs. |
| F3 | The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction. |
| F4 | In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 28, 2024. |
Chief Corporate Development Officer